Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
587.09B | 482.31B | 537.20B | 535.23B | 412.76B | Gross Profit |
103.47B | 72.39B | 72.37B | 108.65B | 73.21B | EBIT |
0.00 | 11.15B | 12.98B | 48.70B | 24.96B | EBITDA |
45.82B | 25.56B | 15.49B | 52.20B | 28.34B | Net Income Common Stockholders |
31.39B | 15.93B | 14.69B | 44.55B | 26.56B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
102.37B | 82.30B | 74.88B | 73.82B | 78.20B | Total Assets |
556.52B | 480.08B | 471.16B | 504.15B | 396.51B | Total Debt |
27.44B | 17.97B | 50.43B | 11.01B | 6.82B | Net Debt |
-66.60B | -61.26B | -18.89B | -56.80B | -49.96B | Total Liabilities |
259.33B | 221.10B | 244.28B | 257.72B | 181.87B | Stockholders Equity |
269.54B | 239.82B | 212.38B | 232.33B | 201.76B |
Cash Flow | Free Cash Flow | |||
5.47B | 50.05B | -29.38B | 22.67B | 11.01B | Operating Cash Flow |
8.03B | 52.09B | -27.45B | 25.19B | 14.04B | Investing Cash Flow |
-3.19B | 2.21B | -4.12B | -6.67B | -8.80B | Financing Cash Flow |
4.81B | -45.24B | 7.81B | -16.14B | -10.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $15.35B | 12.81 | 14.34% | 1.97% | 20.50% | 63.01% | |
78 Outperform | $26.86B | 24.26 | 21.03% | ― | 82.10% | 6.35% | |
70 Outperform | $20.57B | 18.44 | 114.33% | 2.09% | 5.46% | 23.49% | |
66 Neutral | $22.32B | 15.20 | -109.27% | 2.70% | 36.29% | ― | |
66 Neutral | $17.16B | 9.46 | 28.45% | ― | 21.22% | ― | |
63 Neutral | $27.13B | 10.34 | 84.33% | 3.94% | 1.03% | -18.56% | |
60 Neutral | $11.64B | 10.63 | -6.94% | 2.93% | 7.63% | -11.15% |